Bioprocess and manufacturing at World Vaccine Congress 2027
Mar 8–11, 2027 Washington, DC ~3k attendees Website
34 organizations at World Vaccine Congress 2027 present work in bioprocess & manufacturing: 31 suppliers and service providers, 2 public-health and non-profit bodies and 1 vaccine or drug developer. Between them they bring 8 presentations to the program. Most represented: CEPI (7 on the program), Pfizer (4 on the program), Vaccine Formulation Institute (2 on the program). As of Oct 8, 2026.
Format
Top represented
Showing 1–18 of 34 organizations
| Organization | World Vaccine Congress 2027 Attendance |
|---|---|
CEPI Oslo, Norway | |
Coalition for Epidemic Preparedness Innovations: global partnership funding vaccines against emerging infectious diseases and epidemic threats. | Talk Wed Mar 10 09:10 Panel Wed Mar 10 09:10 Talk Wed Mar 10 16:40 Deep Dive Session: Non-animal preclinical systems for vaccine development and pandemic preparedness How organoids and organ-on-chip systems could replace some animal studies in early vaccine testing and pandemic preparedness. |
Pfizer New York, NY | |
Global pharmaceutical company with a vaccine portfolio spanning pneumococcal, RSV, COVID-19 and other infectious diseases. | Keynote Tue Mar 9 14:55 The Longevity Dividend: Scaling Adult Immunization for an Aging Global Population How vaccines for older adults can overcome age-related immune decline and a crowded adult schedule, and how to raise low uptake worldwide. Clinical & preclinical developmentSupply, safety & access Talk Wed Mar 10 15:10 |
Swiss centre of expertise in adjuvants and vaccine formulation that develops adjuvants and supplies them at GMP grade under open-access terms. | Talk Mon Mar 8 10:00 Global Health Workshop How to move vaccines for poorer countries past long-standing roadblocks in development, and what shapes fair access in low-resource settings. Supply, safety & accessInfectious disease & AMR |
VA Vaccine Analytics | |
Talk Wed Mar 10 14:40 | |
Indian contract research and development company specializing in difficult-to-express recombinant proteins across yeast, microbial and mammalian systems. | Booth Exhibiting at Booth 468 |
ABL Rockville, MD | |
Contract developer and manufacturer of vaccines, gene therapies and oncolytic viruses, with preclinical and bioanalytical testing services. | Booth Exhibiting at Booth 439 |
Agilent Santa Clara, CA | |
Supplies analytical instruments, software, consumables and lab services used to characterize and test vaccines and other biologics. | Booth Exhibiting at Booth 432 |
Ambient Biosciences Ann Arbor, MI | |
Maker of stabilizers and sample collection kits that keep biomolecules stable at room temperature, avoiding cold chain and freeze-drying. | Booth Exhibiting at Booth 249 |
CDMO offering one-stop development and manufacturing of mRNA vaccines and therapeutics, with research support from group company Axcelead DDP. | Booth Exhibiting at Booth 230 |
Biodextris Montreal, Canada | |
Contract developer and manufacturer of complex biologics, taking programs from discovery to late-stage clinical supply. | Booth Exhibiting at Booth 423 |
Chinese maker of vaccine adjuvants, including QS-21 and monophosphoryl lipid A products. | Booth Exhibiting at Booth 428 |
Group of contract testing and manufacturing companies, including Clean Cells and Naobios, serving vaccine and biologics developers. | Booth Exhibiting at Booth 538 · Naobios |
Croda Snaith, United Kingdom | |
Supplies vaccine adjuvants, lipids for mRNA delivery and high-purity excipients to vaccine and drug developers. | Booth Exhibiting at Booth 319 |
Cytiva Marlborough, MA | |
Supplies bioprocess equipment, single-use systems, chromatography and cell culture products for biologics and vaccine manufacturing. | Booth Exhibiting at Booth 234 |
Cytovance Biologics Oklahoma City, OK | |
Contract development and manufacturing organization producing biologics from microbial and mammalian expression systems. | Booth Exhibiting at Booth 373 |
Supplies quillaja saponin extracts, including QS-21 vaccine adjuvant material produced at GMP scale. | Booth Exhibiting at Booth 442 |
Supplier of non-animal triterpene oils used in emulsion vaccine adjuvants, including mimics of commercial adjuvants and new combination adjuvants. | Booth Exhibiting at Booth 358 |
Fina BioSolutions Rockville, MD | |
Supplies CRM197 carrier protein and conjugation expertise to developers of conjugate vaccines. | Booth Exhibiting at Booth 534 |
Instantly find 20 buyers in bioprocess & manufacturing
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Browse World Vaccine Congress 2027 by
Organization type
Topic
Exhibit hall
Everyone
Not affiliated with or endorsed by the World Vaccine Congress or its organizers. Submit a correction